filmov
tv
Anti-TNF Outcomes
Показать описание
Is there new information on how Anti-TNF medications affect outcomes of COVID-19? Is it protective? Is it dangerous?
Crohn's and Colitis Canada
chrons
crohns
colitis
ibd
covid-19
Рекомендации по теме
0:02:00
Anti-TNF Outcomes
0:18:23
Who should receive early anti-TNF therapy: With what benefits and risks?
0:15:09
Novel Targets and Therapeutic Perspectives in IBD: Beyond Anti-TNF
0:14:13
What do we do when the patient loses their response to an anti-TNF?
0:23:36
Revisiting Anti-TNF 20 Years Later
0:10:25
CON: Anti-TNFs should be used before Vedolizumab for moderate to severe IBD
0:26:25
Understanding non-response and loss of response in IBD: Which is it and when do we change classes?
0:12:04
PRO: Vedolizumab should be used before anti-TNFs for moderate to severe IBD
0:15:14
PRO: All Medications May be Stopped for Crohn’s Disease Patients in Remission
0:26:49
Update on the therapeutic drug monitoring in IBD: For use in situations other than loss of response?
0:18:38
Positioning anti-IL-12 and anti-IL-23 inhibitors
0:22:47
A practical guide for the use of therapeutic drug monitoring
0:12:35
Best of the Day: ACG2016 - Anti-TNF Therapy
0:07:06
CON: We are not yet ready to use Vedolizumab in Pediatric IBD
0:25:22
IBD and Pregnancy
0:03:32
Fighting Arthritis: the development of anti-TNF therapies
0:12:32
Psoriasis in women: Management challenges | Mahira Hamdy El Sayed, MSc, MD | Egypt
0:12:32
Use of anti-TNF therapies for Crohn's disease
0:18:01
Debate: Combination or monotherapy with anti-TNF? - Combination
0:16:10
When should we stop anti-TNF therapy and how do we then treat the patient?
0:32:39
Manage anti-TNF Failure in Hospitalized Severe Patients with Ulcerative Colitis - Dr. Peter Higgins
0:21:59
The treatment of moderate to severe IBD with anti-TNF biologics and immunomodulators
0:23:55
New Biologic Therapies that Target the IL-12/23 Pathway
0:20:22
Consequences of TNF Inhibition